- Market Capitalization, $K 207,757
- Shares Outstanding, K 40,263
- Annual Sales, $ 114,470 K
- Annual Income, $ 22,300 K
- 60-Month Beta 1.07
- Price/Sales 1.86
- Price/Cash Flow 8.19
- Price/Book 1.72
|Period||Period Low||Period High||Performance|
| || |
+0.01 (+0.19%)since 09/18/19
| || |
-0.81 (-13.57%)since 07/18/19
| || |
-0.59 (-10.26%)since 10/18/18
Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief Executive Officer, will provide a corporate overview at the 2019 Cantor Global...
Based on the Extended Term, Kamada Projects Revenues from Sales of GLASSIA to Takeda During 2019-2021 to be in the Range of $155 Million to $180 Million
Kamada Ltd. (Nasdaq: KMDA; TASE: KMDA.TA), a plasma-derived protein therapeutics company, reports that it is currently in discussions with Takeda to extend the period prior to transitioning the manufacture...
Kamada (KMDA) delivered earnings and revenue surprises of 6.67% and 4.12%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
-- Total Revenues for Second Quarter of 2019 were $35.3 Million, a 4% Increase Year-Over-Year
Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the second quarter and six months ended June 30, 2019, prior...
Kamada (KMDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Kamada, Anhui Conch Cement, Air China and Air Transport Services
Cash is an indispensable factor for any company. It gives strength and vitality to a company and is the key to its existence, development and success.
Zacks.com featured highlights include: Kamada, SunCoke Energy, Great Lakes Dredge & Dock, Herc and SYNNEX